Loading
Buscar en Drogas México

   

Harm Reduction 2010 :: Drogas México
autor

International Harm Reduction Association

EU drug strategy 2013-2020 strong on harm reduction, human rights, civil s
Harm Reduction 2010
Harm Reduction 2009


IHRA’s 21st International Conference Welcome to ‘Harm Reduction 2010: IHRA’s 21st International Conference’.

These conferences have been held around the world for two decades and, for 2010, we are returning to the city which hosted the first conference in 1990 – Liverpool, England.Over five days, this conference will be the main meeting point for all
...

ABR
25
2 0 1 0

1 comentarios


Harm Reduction 2010

Aram Barra, International Harm Reduction Association

25 de abril de 2010 (17/03/10)
International Harm Reduction Association ver en ihra.net

IHRA’s 21st International Conference



Welcome to ‘Harm Reduction 2010: IHRA’s 21st International Conference’.

These conferences have been held around the world for two decades and, for 2010, we are returning to the city which hosted the first conference in 1990 – Liverpool, England.

Over five days, this conference will be the main meeting point for all those interested in harm reduction, and an invaluable platform for advocacy, debate, and discussion. For nearly two decades, these events have been the key forum for the dissemination of harm reduction ideas and practice, and have helped to put harm reduction on the map.

Session Overview

Date: Sunday, 25/04/2010
4:00pm - 6:00pm OPENING SESSION: Michel Sidibé - Keynote Opening Address
Room 1+1A
Gerry Stimson_ Executive Director. IHRA
Michael Brown_ Vice-Chancellor. Liverpool John Moore's University
Paul Hayes National Treatment Agency for Substance Misuse Executive Director
Mat Southwell_ Head of the International Network of People who Use Drugs
Allen Frimpong_ Head of YouthRISE
Paddy Costall_ Managing Director. Conference Consortium
Pat O'Hare - presentation of International Rolleston Award for 2010
_ President of IHRA


Date: Monday, 26/04/2010
9:00am - 10:30am P1: Harm Reduction: Next Generation Challenges
Room 1+1A
How succcessful have global efforts to expand HIV prevention been?: results of a global systematic review
Bradley Mathers, Hammad Ali, Louisa Degenhardt, Richard Mattick, . Reference Group to the UN on HIV and Injecting Drug Use
Three Cents A Day Is Not Enough: Resourcing HIV Harm Reduction On A Global Basis
Gerry Stimson, Catherine Cook, Jamie Bridge, Javier Rio-Navarro, Rick Lines, Damon Barrett
The Global Fund’s Leadership on Harm Reduction
Rifat Ali Atun, Michel Kazatchkine, Urban Weber
A health systems strengthening approach to development financing: what does it mean for harm reduction?
Alvaro Bermejo, Susie McLean

11:00am - 12:30pm M01: Young Drug Users: Emerging Drugs and New Trends Room 1
Youth Centered Treatment- Having Youth at the Center of Harm Reduction
Allen Kwabena Frimpong, Chantale Kallas
Invisible for the state! Iulia-Veronica Broasca
Young people, harm reduction and non-injectable drugs Aram Barra
Advocacy for Harm Reduction in Oyo State, Nigeria: Lesson Learned
OREOLUWA Kolawole Muyideen
Youth RISE Up HIV Prevention! Workshop
Kyla Kyla Zanardi, Veronica Broasca

11:00am - 12:30pm M02: Harm Reduction in Europe
Room 3
Harm reduction in Europe: the historical and political context, current perspectives and future challenges
Paul Griffiths, Roland Simon, Dagmar Hedrich, Tim Rhodes
Global drug policy developments in the past decade: looking for a balance between harm reduction and repression
Franz Trautmann
A European Harm Reduction Network: Strengthening Civil Society to Promote and Defend Harm Reduction
Jamie Bridge, Matthew Geoffrey Southwell
Harm reduction in Europe - experiences, lessons learnt and what's next
Eberhard Schatz, Katrin Schiffer


11:00am - 12:30pm M03: Evidence in Harm Reduction
Room 11
Fear and structural violence as barriers to harm reduction: Qualitative case studies on police violence in Russia and Serbia
Tim Rhodes, Anya Sarang, Milena Simic
A review of the evidence for peer-driven interventions in harm reduction and examples of recent applications in new populations and areas of intervention—the PROZE trial.
Jean-Paul Grund, Dick de Bruin, Minke Dijkstra, Christel Meierman, Mariette Baas, Robert Broadhead
The Canadian Randomized Trial of Diacetylmorphine vs. Methadone for Opioid Addiction
Eugenia Oviedo-Joekes, David Marsh, Suzanne Brissette, Daphne Guh, Pierre Lauzon, Bohdan Nosyk, Aslam Anis, Martin T. Schechter
The Global State of Harm Reduction 2010
Catherine Joanne Cook

2:00pm - 3:30pm C01: Youth-Friendly Harm Reduction Interventions
Room 1
What is needed in order to move into the next decade of harm reduction? – A Young Person’s Approach.
Mags Bojthe
A Harm Reduction Response within Drug Education
Catherine Byrne
‘One Way Ticket to Hell’ for young migrant drug users in Myanmar
Thinzar Tun, Willy De Maere, Thein Han
“Opening Doors” – a participatory approach to increasing access to and participation in youth friendly harm reduction
John Howard, Gerard de Kort, Bijay Pandey, Luo Jian, Sarah Larney
Reducing Harmful drug practices among young people in Land border Communities in Nigeria, The YDI example
Femi Aina Fasinu


2:00pm - 3:30pm C02: Challenges in Drug Treatment
Room 3
Methadone as HIV Prevention: High Volume Methadone Sites to Decrease HIV Incidence Rates in Resource Limited Settings
R. Douglas Bruce
What is the role of harm reduction when drug users say they want abstinence?
Joanne Neale, Sarah Nettleton, Lucy Pickering
Bioethical preferences of supporters and opponents of OST in Russia
Mendelevich Vladimir
Scaling up the Methadone Maintenance Therapy Program in Vietnam based on preliminary outcomes of a pilot intervention
Long Thanh Nguyen, Huynh Thi Nguyen, Giang Truong Le, Cong Van Vu, Mai Quynh Nguyen, Nhu To Nguyen, Hoang Vu Tran, Minh Huy Pham, Thai Nam Hoang, Rachel Burdon, Stephen Jay Mills, Kevin P Mulvey, Ngoc Thi Minh Nguyen, Hong Thu Nguyen, David Jacka, Robert Ali

2:00pm - 3:30pm C03: Harm Reduction Policies: Challenges for Developed or Well-Funded National Approaches
Room 11
Scale down of harm reduction in Eurasia: what the next generation will be?
Simona Merkinaite, Shona Schonning
Harm Reduction in Indonesia: Challenges and Opportunities
Rizky Ika Syafitri, Ignatius Praptoraharjo, Octavery Kamil, Irwanto Irwanto, Nasrun Hadi
Harm reduction in Canada: one step forward and two steps backwards
Walter Cavalieri, Diane Riley
From institutionalization to regression, the French case
Fabrice Olivet


2:00pm - 3:30pm C04: Drug Consumption Sites: Politics and Research
Room 1A
Medical students in a safe injecting facility: an innovative way of improving future medical care for drug users?
Anne Franois, Christophe Mani, Barbara Broers
Politics versus Public Health and Supervised Injecting Centres in 2010
Marianne Jauncey, Eberhard Schatz
'Hanging On' to Insite - The Socio-Political Context of a Community fighting to keep an Injection Site
Liz Evans
Routine monitoring in the Geneva Drug Consumption Room (DCR) 2002-2008
Franoise Dubois-Arber, Giovanna Meystre-Agustoni, Cedric Gumy, Christophe Mani, Martine Baudin, Thérse Huissoud


2:00pm - 3:30pm C05: Route Transition Interventions: Public Health Gains from Preventing or Reducing Injecting
Room 4
Targets for change – injection initiation and modeling behaviours
Carol Strike, Gilllian Kolla, Raffi Balian, Jason Altenberg, Rey {Butch} Silver, Karen Burton, Brian Lester, Elise Roy, Neil Hunt, Peggy Millson
Break the Cycle: opportunities and challenges for preventing initiation into injecting in Eastern Europe
Neil Hunt
Heroin Snorters - a group neglected by harm reduction
Martin Busch, Alexander Eggerth
How an entire generation of injectors switched to non-injecting. The Dutch experience on promoting the transition away from injecting, 1990 -2009. A case study, analysis and lessons learned.
John-Peter Kools


2:00pm - 3:30pm C06: Insights From Qualitative Research
Room 12
Perceived consequences of refusing to share injection equipment: A qualitative study
Karla D. Wagner, Stephen E. Lankenau, Lawrence A. Palinkas, Jean L. Richardson, Chih-Ping Chou, Jennifer B. Unger
‘Because I’ve been extremely careful.’ Responsibility, HIV and the neo-liberal drug-using subject
Andrea Krüsi, Will Small, Cody Callon, Evan Wood, Thomas Kerr
Social barriers to the utilization of pharmacy sales of syringes in Tijuana, Mexico
Peter J Davidson, Remedios Lozada, Manuel Gallardo, Perth Rosen, Armando Macias, Meghan Morris, Lawrence Palinkas, Robin A Pollini
Models of Drug Use and Mechanisms of Regulation and Control: a qualitative study in Russia
Anya Sarang


4:00pm - 5:30pm C07: Using Naloxone to Prevent Fatal Overdoses: Innovations and Programmes
Room 1
Naloxone: A missing link in Harm Reduction in China
Deming Xin
Overdose prevention in Gorno Badakhshan Autonomous Region (GBAO) of Tajikistan
Maram Azizmamadov
Naloxone Distribution in Chicago, USA: Honoring Life Really Makes a Difference
Dan Bigg, John Gutenson
Overdose: A major Cause of Preventable Death in Central and Eastern Europe and Central Asia
Simona Merkinaite, Shona Schonning, Phillip Coffin, Egija Lapina Egija Lapina, Mikhail Torban, Valentin Simionov Valentin Simionov, Maram Azizmamadov Maram Azizmamadov, Sherboto Tokombaev Sherboto Tokombaev, Madina Tokombaeva Madina Tokombaeva, Anya Sarang Anya Sarang, Raminta Stuikyte Raminta Stuikyte
Introducing 'take home' naloxone in Wales - from strategic direction to implementation
Danny Morris, Rhian Hills, Dr Rossana Oretti, Ifor Glyn


4:00pm - 5:30pm C08: Substitute Prescribing
Room 3
Methadone Diversion: Why it happens, what the illicit market looks like and the implications
Paul Duffy, Helen Baldwin
“Sometimes our people get tossed out of the system.” Accessibility and appropriateness of Methadone Maintenance Treatment/Therapy (MMT) and harm reduction services for Aboriginal peoples in British Columbia, Canada
Tessa Parkes, Dennis Wardman
Improving outcomes and quality of life for people on MMT: The enhanced pharmacy services (EPS) RCT
Mariesha Anne Jaffray, Catriona Matheson, Christine Bond, Allan Johnstone, Amanda Lee, Lucy Skea, Bruce Davidson
Methadone Subtitution Therapy- The Mauritian Context
Fayzal Sulliman, G. Hussein Rassool


4:00pm - 5:30pm C09: Harm Reduction Policies: Challenges for Developing National Approaches
Room 11
Working in the dead zone: harm reduction with conflict-affected and displaced populations
David Stewart Macdonald
Effects of UN and Russian influence on drug policy in Central Asian countries of the Commonwealth of Independent States (CIS)
Leah Utyasheva, Richard Elliott
Closed for reasons?! Lessons learned from closure of opioid substitution therapy in Uzbekistan
Azizbek Ataevich Boltaev, Raminta Stuikyte, Alec Khachatrian
Inter-Parliamentary working group in Central Asia – additional approach to HIV epidemic in the region
Chinara Seitalieva, Tilek Meimanaliev, Shifo Niyatbekov, Gulya Kolakova


4:00pm - 5:30pm C10: Health, Risk and Injection Drug Use
Room 1A
The International Research on Racial/Ethnic Disparities in HIV Infection among Injection Drug Users (IDUs)
Don Des Jarlais, Holly Hagan, Heidi Bramson, Karla Gostnell, Cherise Wong
Prevalence of HIV, HCV and other Sexually Transmitted Infections and associated risk behaviors among Spanish and immigrant IDU in Catalonia, Spain
Cinta Folch, Jordi Casabona, Xavier Majó, M. Teresa Brugal, Merc Meroño, Victoria González, Grupo REDAN
Syringe Type and HIV Risk: Current Knowledge and Future Directions
William A. Zule, Georgiy V. Bobashev, Curtis M. Coomes, Don C. Des Jarlais, Samuel R. Friedman, Anna Gyarmathy, David Otiashvili, Winona Poulton
Laying foundation of Harm Reduction in resource poor setting of Pakistan
Naeem Hassan Saleem

4:00pm - 5:30pm C11: Children and Young People Affected by Drugs
Room 4
“I still love my mum”: tensions in how children and young people talk around parental substance misuse
Kathrin Houmller, Sarah Bernays, Tim Rhodes, Sarah Wilson
Patterns of Injecting Drug Use among Street Children in Ukraine
Joanna Rose Busza, Olga Balakireva, Anja Teltschik, Tetiana Bondar, Yuliya Sereda, Olena Sakovych
“The Kids Are Alright”: minimising harm to children of substance users
Lisa Sturrock
Healing Ourselves: Supporting drug-using mothers who have lost children
Amy Salmon, Sydney Weaver, Stephanie Gloyn


4:00pm - 5:30pm C12: Dance Drugs and Legal Highs
Room 12
legal highs- a challenge for policy makers
Adam Winstock
Legal highs, research chemicals, novel psychoactive drugs, and the Internet: The challenge for harm reduction
Zoe Davey, Ornella Corazza, Fabrizio Schifano, Paolo Deluca
From Pills and Powders to Plant Feed: Deterrence, displacement and harm reduction in a climate of successful supply reduction
Fiona Measham, Karenza Moore, Zoe Welch
K-Day - Bridge-building in Action: An example of collaboration around an emerging drug trend between the drug using community, academics and practitioners
Matthew Geoffrey Southwell, Celia Morgan


Date: Tuesday, 27/04/2010
9:00am - 10:30am P2: The Next Generation of Drug Policy: Decriminalisation and Beyond
Room 1+1A
Shift of Paradigm in Drug-related Public Policies in the Argentine Republic and Latin American countries
Martín Edgardo Vázquez Acuña
Decriminalisation: Pushing the Limits of Drug Control
Ann Fordham, Dave Bewley-Taylor
National Strategy on Drugs in Portugal: Innovation and Evidence
Fatima Trigueiros
After the war on Drugs; Blueprint for Regulation
Stephen Anthony Rolles


11:00am - 12:30pm M04: Mental Health and Drug Use
Room 1
The production of stigma by the disease model of addiction: why drug user activists must oppose it
Eliot Ross Albert
working together
Lynda Poirier, John Goedike
Lesson for Harm Reduction Model from a French psychiatric experience of a therapeutic squat for homeless with dual diagnosis in Marseille (France). How can we develop the Harm reduction model in the mental health field.
Girard Vincent
Drug Treatment and Co-occuring Disorders in Jamaica
Howard Almando Gough
Self-Medicating to Survive: A Critique of "Dual Diagnosis/Concurrent Disorders" to Expose the Myth of "Addiction" as a Disease and Promote Harm Reduction Policies that Enhance Pleasurable Illicit Drug Use
Cheryl Lynn White


11:00am - 12:30pm M05: Tobacco Harm Reduction: Healthier So Why Not Acceptable?
Room 3
Snus as a virtually safe alternative to smoking: a review of the evidence
Peter N Lee, Jan Hamling
Tobacco harm reduction is economically and ethically superior to policies of abstinence
Carl V Phillips
Tobacco Harm Reduction: Need for a more holistic regulatory framework
Adrian Nigel Payne
Tobacco and The Future of Harm Reduction
Ernest Drucker


11:00am - 12:30pm M06: Gender Issues in Harm Reduction
Room 11
The Latest Frontier for the War on Drugs: The Womb
Theshia Naidoo, Tamar Todd
“It’s just one of those things”: Living with hepatitis C and contextual meanings of health among women who inject drugs
Anna Olsen, Cathy Banwell, Phyll Dance, Lisa Maher
Increasing capacity for gender-sensitive harm reduction in Eastern Europe and Central Asia
Sophie Pinkham
Plight of Female drug user’s in Nepal
Dul Maya Pun


2:00pm - 3:30pm C13: Harm Reduction and Human Rights
Room 1
Treatment or torture?: Applying international human rights standards to compulsory drug dependence treatment
Richard Elliott, Alison Symington, Y.Y. Chen, Patricia Allard
The illegal arrest, arbitrary detention and torture of people who use drugs in Cambodia
Richard Pearshouse
Human rights bodies must defend drug users’
Rajesh Khongbantabam


2:00pm - 3:30pm C14: Legal and Policy Developments
Room 3
What can be done under the new Drug Control Law in China?
Yu Liu, Xiuyi Lv, Juncheng Liang, Chengzheng Zhao, Longhui Li, Yahai Zhang, Wenhua Zhou
Shooting Three Birds With One Stone - Reducing Crime, Drug Use And Harm By Treating Substance Abuse
Mohd Zaman Khan Rahim Khan, Christoffer Erichsen, Shariha Khalid
Argentines Supreme Court Declaracion about unconstitutionality of punishment for drug possession and consumption and new risks for drug users. The challenges for harm reduction on times of changes and misunderstandings
Silvia Inchaurraga
Harm reduction as official city policy in a U.S. city—how helpful can it be?
Laura Thomas, Meghan Ralston
FRENCH SYSTEM: institutionnalisation and addictology: what's happenning?
Beatrice Stambul, AFR board


2:00pm - 3:30pm C15: Integrating Harm Reduction Into Medical Practices
Room 11
The role of primary care as a model of integrating comprehensive care and treatment
Christine Helen Ford, Kate Halliday, Elsa Browne
Why we need a network for harm reduction doctors? Doctors informing drug policy: a development perspective
James Rowan Blogg, Chris Ford
Public Health Project Coordinator
Zumrat Yakubjanovna Maksudova, Nigora Nafizovna Abidjonova
One step to integration of harm reduction into narcology clinic in Russia (Kazan)
Khalabuda Liliya, Zaripov Albert


2:00pm - 3:30pm C16: Needle and Syringe Programmes
Room 1A
Prevalence and predictors of transitions to and away from syringe exchange use over time in 3 US cities: The Impact of Syringe Dispensing Policy Changes
Traci Craig Green, Ricky N. Bluthenthal, Merrill Singer, Leo Beletsky, Lauretta E. Grau, Patricia Marshall, Robert Heimer
Report on the outcomes of a 5 year DFID-funded Harm Reduction project implemented by government in 21 provinces in Viet Nam
David Jacka, Nguyen Thanh Long, Nguyen Thi Huynh, Masami Fujita, Peng Fei Zhao, Nguyen Thien Nga, Huu Trinh Vach
“One Man’s Junk: Building support for harm reduction through community engagement around drug litter”
Sara Kathryn Young, Sandra Dunn
Bradford Needle Exchange Database
John Bolloten


2:00pm - 3:30pm C17: Social Science Research Methods
Room 4
Agent-based modelling: One response to complexity and relevance in drug research and policy
David Moore
Hepatitis C and its social and political complexities: Generating relevant knowledge for policy
Suzanne Fraser
Use of Appreciative Inquiry Methods in Evaluating Harm Reduction Programs
Dave Burrows


2:00pm - 3:30pm C18: Harm Reduction for People who Use Prescription Drugs
Room 12
Harm Reduction for Prescription Opioid Users: A New Frontier for Harm Reduction
Scott Burris, Dave Burrows
Project Lazarus - Community-based overdose prevention for medical and non-medical prescription opioid users
Nabarun Dasgupta, Fred Wells Brason II, Catherine Sanford, Susan Albert
Geographic and contextual factors of prescription opioid abuse in the United States: Results from ASI-MV Connect
Traci Craig Green, John Brownstein, Stephen F Butler
Chronic Pain is Common among Opioid Abusers in Maine, USA
Robert Heimer, Kevin Irwin, Mark Kinzly, Nabarun Dasgupta, Anthony Givens, Lauretta E. Grau
Pulmonary disease in IDUs: time to use novel tools for reducing harm from filler particles due to injection of pharmaceutical products
Roux Perrine, Carrieri M.Patrizia, Keijzer Lenneke, Dasgupta Nabarun


4:00pm - 5:30pm C19: Introducting Harm Reduction in the Middle East and North Africa
Room 1
Hepatitis B and C among IDU: whose business is it?
Joumana Hermez
Evidence-Based Design of the IDU component of the national HIV response in Pakistan
Adnan Ahmad Khan, Ayesha Khan
Lessons learnt from Médecins du Monde Harm Reduction programme in Afghanistan.
Olivier Maguet, Murtaza Majeed
Harm Reduction Networks and the Global Fund – lessons learned from a civil society application
Elie Aaraj, Gerry Stimson, Joumana Hermez, Annette Vertser


4:00pm - 5:30pm C20: Law in Action: Legal Aid for People who Use Drugs
Room 3
On-line legal aid to Russian drug users
Irina Khrunova
Drug users deserve more than criminalization and prosecution; let's face it.
Pfiriael Kiwia, Bernard Ukuta, Gideon Wilson Mlekang'ombe, Janeth Franklin Ngowi
Access to Justice for Drug User: A Community Legal Empowerment Approach in Indonesia
Ricky Gunawan
Reclaiming treatment as a right: drug litigation in India
Tripti Tandon


4:00pm - 5:30pm C21: Policy Barriers Faced by Pregnant and Parenting Women Who Use Drugs
Room 11
Drugs, Pregnancy and Parenting: US Legislation, Policy and Practice
Lynn M. Paltrow
Barriers of Care Impacting Perinatal Outcomes – The Vancouver Experience
Ronald Abrahams
integration of services and best practices of NGOs in State structure
Maksym Demchenko
Fighting Stigma to include Gender Sensitive Programming in Eastern Europe
Daria Ocheret


4:00pm - 5:30pm C22: Peer Driven Interventions
Room 1A
Before you get burnt: University Peer Education
Irma Silva Brito, Fernando Mendes, Marcia Santos, Filipa Homem
Strengthen peer network by creating enabling environment in Myanmar, South East Asia
Dr. Zaw Thein Oo, Dr. Nang Pann Ei Kham, Htun Htun Lynn, Ye Min Htun, Chad Hughes
Double jeopardy: ensuring that people who inject drugs involved in harm reduction and peer distribution are not placed in harm’s way of contradictory policy and law.
Sione Crawford
Meaningfully Driven
Raffi Balian, Jason Altenberg, Molly Bannerman


4:00pm - 5:30pm C23: Cannabis Normalisation: Cross-National Perspectives, Evidence and Implications
Room 4
An Australian Perspective on Cannabis Normalization: The backlash against progressive policies: Recriminalization of cannabis use in Western Australia
Simon Lenton
A Dutch Perspective on Cannabis Normalization: Testing the Limits of the Concept
Dirk J. Korf
The Normalisation of social drug dealing: The extension of a concept (and where does it stop?)
Ross Coomber
A Canadian Perspective on Cannabis Normalization among Adults: Has all the Stigma Gone?
Mark Asbridge, Pat Erickson, David Marsh, Cameron Duff, Serge Brochu, Marie-Marthe Cousineau, Andrew Hathaway


4:00pm - 5:30pm C24: Perspectives on Stimulants
Room 12
Meth, Panic and Harm Reduction: Understanding the Opponents of Harm Reduction
Connie I. Carter
Harm reduction advice based on the analysis of crack cocaine seizures in Swindon (UK)
Jenny Scott, Michael Rowan
Incidence of HIV and Sexually Transmitted Infections among Young Women Sex Workers in Phnom Penh, Cambodia
Marie-Claude Couture, Lisa Maher, Neth Sansothy, Vonthanak Sapphon, Serey Phal, Keo Sichan, Ellen Stein, Jennifer Evans, John Kaldor, Mean Chhi Vunn, Kimberly Page
Meth Injection & HIV Risk in Russia: political response and practice.
Olga Borodkina, Robert Heimer, Kevin Irwin, Andrey Kozlov
Mental health, drug use and risk among gay, lesbian and bisexual community members in Sydney, Australia who report regular methamphetamine use
Amanda Roxburgh, Angela Matheson, Louisa Degenhardt



Date: Wednesday, 28/04/2010
9:00am - 10:30am M07: Shining a Light on the System: Using Monitoring and Advocacy to Effect Change
Room 1
Claiming Justice and Care: Essential findings on police abuses against drug users in Indonesia
Atikah Nuraini
Empowering Patients: The Experience of the All-Ukrainian OST Patients Association
Olga Belyaeva
Drug users defend patients’ rights in Kyrgyzstan
Lev Babenko
Innovative ways to engage PWUD and PLHIV in advocacy through patients’ monitoring and evaluation
Evgenia Maron, Anastasia Meylakhs, Albert Zaripov, Gregory Vergus


9:00am - 10:30am M08: Tuberculosis and Integrated Care for People Who Use Drugs
Room 3
Integrated care for IDUs in practice: Results of an assessment of implementation experience in 7 recently created integrated care centres in Ukraine
Kostyantyn Dumchev, Gundo Weiler, Sergiy Dvoriak, Irina Grishayeva, Elena Forostyana
Integrated TB/HIV and substitution therapy services for Drug Users: Case Studies from 4 countries
Theo F Smart
Prioritizing TB as major component in six sites Harm Reduction Programs in Myanmar
Yin Min Thaung
Models of Integrated TB Treatment for Drug Users in Kyrgyzstan, Russia, and Ukraine
Marina Smelyanskaya, Janna Ataiants
Integrated TB/HIV services - from Policy to Action: the need for activism
Alasdair Reid


9:00am - 10:30am M09: Responsible Hospitality: Reducing Harm in the Nightlife Economy
Room 11
Reducing Harm in Drinking Environments
Lisa Jones, Karen Hughes, Amanda Atkinson, Mark A Bellis
Where are we coming from, where are we going? 'Partnerships' as an approach to reducing alochol related harm at local level
Rachel Frances Herring
Making Drunkenness Socially Unacceptable - Part one
Adam F Chafetz


11:00am - 12:30pm M10: The War Against Sex Workers
Room 1
Resisting Raids & Violence Against Sex Workers: a community empowerment approach in Kyrgyzstan
Dinara Jarmamatovna Bakirova
Cross Cultural Peer to Peer Capacity Development: The Fijian Experience
Nicolette Estelle Burrows
Mobilization of national and international communities against raids, human rights violations and criminalization of sex workers in Macedonia
Marija Tosheva
Getting in the door, getting to the microphone, getting to be heard - a long journey: making space in civil society for sex workers’ rights.
Catherine Stephens


11:00am - 12:30pm M11: Viral Hepatitis A, B and C: An Overview
Room 3
Viral hepatitis in people who inject drugs: epidemiology, current response and proposed priorities
Nick Matthew Walsh, Annette Verster
Brazilian experience in providing HCV (Viral Hepatitis) assistance and prevention
Evaldo Stanislau Affonso Araújo
From World Beaters to Dead-Beaters: How Australia failed in its response to the epidemic of Hepatitis C amongst people who inject drugs
Damon Brogan, Jenny Kelsall
Engaging Hepatitis C positive drug users, primarily those who use crack cocaine in an interdisciplinary model of care and treatment.
Zoe Dodd, Daina Hodgson


11:00am - 12:30pm M12: Theories and Philosophies of Harm Reduction
Room 11
A multi-disciplinary theory of drug-related harm reduction
Russell David Newcombe
The Concept of “Moderate Drug Use” as an innovative theoretical framework and its potential for future harm reduction policies
Luis Manuel Falcato, Rudolf Stohler
Harm reduction: It was 20 years ago today and it’s been going in and out of style.
Julian Buchanan
Changing Concepts Midstream: The meaning of tobacco addiction
Stanton Peele


2:00pm - 3:30pm C25: Compulsory Detention of Drug Users: We all know it is happening but what can we do?
Room 1
Compulsory detention of drug users: we all know its happening but what can we do?
Simon Baldwin
Locked up and locked out
Minh Thi Pham, Oanh Thi Hai Khuat
Improved access to services and quality of life for people returning from drug rehabilitation centers in Ho Chi Minh City, Vietnam
Thu Thi Huong Vuong, Hoang Vu Tran, Baldwin Simon, Mills Stephen, Giang Truong Le, Nhu To Nguyen
Engagement with compulsory drug detention centers: a legal and ethical framework
Richard Pearshouse, Amon Joseph J


2:00pm - 3:30pm C26: Clinical and Programmatic Issues around Hepatitis C Treatment
Room 3
Management of hepatitis C in complex patients – alcohol, mental health, HIV and HBV co-infection
Philip Bruggmann
Specialist assessment and treatment of hepatitis C virus infection among injection drug users in New South Wales, Australia
Jason Grebely, Joanne Bryant, Peter Hull, Max Hopwood, Gregory Dore, Carla Treloar
Long-term (5 year) follow-up of Treatment of Chronic Hepatitis C Virus Infection in IVDU in Correctional Institutions and Community settings: Implications for a successful HCV treatment program.
John D. Farley, Garry Horvath, Rob Reynolds, Theresa A. Farley
Resolving barriers to treating HCV among IDU's
Jason Farrell
Uptake and Delivery of Hepatitis C Treatment in Opiate Substitution Treatment: Perceptions of Clients and Health Professionals
Carla Treloar, Jamee Newland, Jake Rance, Max Hopwood


2:00pm - 3:30pm C27: Harm Reduction in European Prisons and Criminal Justice Systems
Room 11
Towards equivalence: Harm reduction services in European criminal justice settings
Alex Stevens, Cinzia Brentari, Karen Skillman
Syringe exchange for intravenous drug users in prison
Hans Wolff, Catherine Ritter, Anne Franois, Franoise Pinault, Barbara Broers
A community-based organization advocacy strategy for a implementing a syringe exchange programme in French prisons: the AIDES experience
Fabrice Pilorge, Sandra Essid, Christian Andreo, Daniela Rojas Castro, Francesca Belli
Post-release overdose deaths – how big is the problem?
Michael Farrell, J Marsden, Garry Stillwell


2:00pm - 3:30pm C28: Parents Who Use Drugs
Room 1A
'Once I’m clean I’m cushty and I can stay clean you know - it’s getting clean' . Hopes and dreams of abstinence in substance misusing mothers' interview accounts
Polly Clare Radcliffe
"Left out:"Father exclusion in harm reduction maternal health services
Sydney Michelle Weaver
Working with family members: A globally neglected aspect of harm reduction
Lorna Templeton


2:00pm - 3:30pm C29: Drug Use in Gay, Lesbian, Bisexual and Transgender Communities
Room 4
Harms and risks encountered by women drug users who have sex with women
Samuel R Friedman, Danielle Ompad, Maria Demarco, Maria Khan
Our livesour issues.our healththe role of drug user organisations in reducing stigma and discrimination among gay, lesbian, bisexual and transgender communities
Nicky Bath
'Don't Share a Bloody Thing and other adventures in harm reduction for gay men
Angela Matheson, Dermot Ryan, Yves Calmette
Targeting London's LGBT Steroid Injectors
David Matthew Stuart


2:00pm - 3:30pm C30: The Internet and Harm Reduction
Room 12
Is there an app for everything? Harm Reduction and the I-phone
Michael Linnell
'BBVsim': a computer model of blood borne virus epidemics amongst injectors
Andrew Preston, Neil Hunt, Edmund Chattoe-Brown
7 years of harm reduction in and by the Hungarian Psychedelic Community DAATH
Levente Móró
Establishment of an Online HIV-Network for IDUs and PLHIV community:
Dhojo Wahengbam


4:00pm - 5:30pm C31: Harm Reduction Projects and Services in Eastern Europe
Room 1
Attitudes towards the provision of services to patients with HIV among Russian drug treatment specialists and their readiness to make HAART available for them
Natalia Dolzhanskaya, Sergey Koren, Yulia Yulina
Social Services Created on the Basis of Harm Reduction Projects in Russia
Elizaveta Berezina
Harm reduction in the context of social inclusion, access to and quality of health systems.
Elena Romanyak
Provision of services for persons with triple diagnosis of HIV/TB/Drug Addiction in Ukraine
Olga Pravdyva


4:00pm - 5:30pm C32: Drug User Networking
Room 3
The movement of “Going out of the closet”; next generation of drug users and activism in Latin America
Oscar Mauricio Montenegro, Silvia Susana Inchaurraga
More in common than not - sexworkers and drug users rights in Sweden
Pye Jakobsson, Sandra Thiang
A “return ticket” for people who use drugs: media/advocacy campaign to promote OST in Ukraine.
Olena Kucheruk
Creative intervention in a creative city for Justice to all drug users
Eka Setiawan


4:00pm - 5:30pm C33: Drug Use and Infections in Prisons: Perspectives From The Inside
Room 11
Monitoring patterns of drug-related risk behaviors among prisoners recruited from prison units with either MMT or NSP
Saman Zamani, Gelareh Mostashari, Marziyeh Farnia, Alireza Torknejad, Masahiro Kihara
Peer Education in Prison Settings
Ludmila Kononenko, Irina Magas, Olena Chupryna
Back on the “Horse”: injecting drug use in the immediate post-prison release period. Results from a prospective cohort study of ex-prisoners with a history of injecting drug users in Melbourne, Australia.
Mark A Stoove, Rebecca Winter, Brendan Quinn, Amy Kirwan
“Under the Skin”: Effective advocacy for HIV prevention in Canadian prisons
Sandra Ka Hon Chu, Richard Elliott


4:00pm - 5:30pm C34: Innovative Approaches to Reducing Non-Viral Health Harms
Room 1A
ECG screening for clients in drug treatment.
Linda Johnstone, Deborah Cox
Promoting Respiratory Health: Current and Novel Harm Reduction Interventions
Lloyd Richard Baron, Caryl Beynon, Jim McVeigh, Martin Chandler
Implanted central venous catheters for intravenous drug users: an ethical dilemma
Barbara Broers, Ihsan Inan, Thomas Rathelot, Bart Kaye, Thierry Musset, Anne Franois, Samia Hurst
Contamination, adulteration and other agents in illicit drugs. A guide for policy makers, practitioners and drug users.
Claire Shaw, Lisa Jones, James McVeigh, Mark Bellis


4:00pm - 5:30pm C35: Staying Safe: Second Generation Approaches to Hepatitis C and HIV Prevention
Room 4
Women Staying Safe in Vancouver
Amy Salmon
Agency, strategy and upbringing: Long-term injectors staying safe from hepatitis C in Sydney
Magdalena Harris, Carla Treloar, Lisa Maher
Luck, chance and good fortune: Accounts of long-term injectors staying safe from hepatitis C in Melbourne
Peter Higgs, Campbell Aitken, Margaret Hellard, Lisa Maher
Staying Safe: Training Injection Drug Users (IDUs) in Strategies to Avoid HCV and HIV Inf1ections
Pedro Mateu-Gelabert, Samuel R. Friedman, Milagros Sandoval


4:00pm - 5:30pm C36: Sex Work and Harm Reduction in the UK: Safety, Skills, and Struggles for Social Inclusion
Room 12
Through pragmatism to possibility - An exploration of how harm reduction principles make a difference to the lives of sex workers
Georgina Perry
Hate Crime, Harm Reduction & Social Inclusion: Addressing violence Against Sex Workers in Merseyside
Shelly Stoops
Contemporary harm reduction & support service needs of male sex workers in the UK: the Sohoboyz male sex worker needs assessment and Skills Development Programme
Justin Gaffney, Joanna Jamel, Christopher Kowalski


Date: Thursday, 29/04/2010
9:00am - 10:30am M13: Harm Reduction for Producer Nations?: Farmers' Perspectives on the War on Drugs
Room 1
Harm Reduction for producer Nations? Farmer’s Perspectives from Burma and Afghanistan on the war on drugs
Tom Kramer
Harm Reduction for producer Nations? Farmer’s Perspectives on the war on drugs - Colombia
Sanho Tree
Harm Reduction for producer Nations? Farmer’s Perspectives from Bolivia on the war on drugs
Pien Metaal


9:00am - 10:30am M14: Ageing Substance Users in the Developed World
Room 3
Drug use and ageing: setting the scene
Caryl Beynon, Brenda Roe, Paul Duffy, Lucy Pickering
A Contextual Analysis of Risk Behaviors Among Older Adult Drug Users and Harm Reduction in Suburban Versus Inner-City Social Environments
Miriam Boeri
Collaborative Research on Harm Reduction: Sociological Insights, Life Course Theory and Mathematical Modeling Techniques Used to Inform Future Research
Miriam Boeri, Thor Whalen
Where is the last generation? Obstacles to accessing treatment amongst older drug users in Bristol, UK.
Rachel M Ayres, Lynne C Eveson, Maggie Telfer


9:00am - 10:30am M15: Policies and developments in Asia and the Pacific
Room 11
Review of Policies, Resources and Services for People Who Inject Drugs in Asia.
Jimmy Dorabjee, Chris Hagarty, Gary Lewis, Fritz Lherisson, Fabio Mesquita, Anne Bergenstrom
Situational assessment of drug and alcohol trends in 16 Pacific Countries and Territories
Robert Power, Lucina Schmich
The Asian Harm Reduction Strategy from 2010 – 2015
Fabio Mesquita, Anne Bergenstrom, Edna Oppenheimer, Cho Kah Sin, Gray Sattler, Jimmy Dorabjee


11:00am - 12:30pm M16: Police and Harm Reduction
Room 1
Instruction for Police Forces for HIV/AIDS prevention in service personnel and vulnerable groups of population. Harm reduction advocacy to police in Kyrgyzstan – more effective regulation within better regulatory frameworks.
Aleksandr Zelichenko
Combined Effects of Police Practices on the Drug-related Harms in Tijuana, Mexico
Tyson Alexander Volkmann, Remedios Lozada, Christy M. Anderson, Thomas Patterson, Alicia Vera, Steffanie A. Strathdee
A framework for taking a harm reduction approach to drug-related enforcement activity
Nicola Singleton
Getting There: Community Policing to Police Social Responsibility- Law enforcement & HIV prevention
Soumen Mitra
Exploring contributing factors limiting the effectiveness of the needle syringe exchange program in Kuala Lumpur, Malaysia
Naomi O'Connor


11:00am - 12:30pm M17: Public Health Surveillance of Infections and Behaviours Among Injecting Drug Users
Room 3
The state of second generation HIV surveillance for IDUs in Europe
Lucas Wiessing, Dagmar Hedrich, Bruno Guarita, Martin Donoghoe, Mika Salminen, Paul Griffiths
Two decades of informing Harm Reduction: Sero-behavioural surveillance of infections among injecting drug users (IDUs) in the UK.
Vivian Hope, John Parry, Andrea Marongiu, Fortune Ncube
The Target Setting Guide: from consensus on the theory to practical roll out.
Annette Digna Verster, Keith Sabin, John Kirkwood
Prove it: Tracking success of harm reduction during 9 years of 2nd generation of HIV surveillance among IDUs in Ukraine
Gundo Weiler, Yuriy Kobyscha, Yuriy Kruglov, Olga Varetska, Tatiana Saliuk, Martin Donoghoe


11:00am - 12:30pm M18: The Use of Anabolic Steroids and Related Drugs
Room 11
The evidence for the harms caused by anabolic steroids and associated drugs
Michael Evans-Brown, Jim McVeigh
The use of performance-enhancing drugs in Denmark: addressing a public health issue through anti-doping programmes designed for elite sport
Andreas Kimergrd
Developing a harm reduction response to the use of anabolic steroids: Geneva, Switzerland.
Barbara Broers, Yves Jackson, Anne Franois, Fabien Ohl, Bengt Kayser
Developing successful harm reduction programmes for performance enhancing drug users — perspectives from South East England
Frank Henderson

1:30pm - 3:00pm P3: Creating Evidence for Action
Room 1+1A
Confronting the Contradictions between Law Enforcement and Harm Reduction: A Twenty-Five Year Ethnographic Perspective on the War on Drugs in the U.S. Inner City
Philippe Irwin Bourgois
Addressing barriers to the implementation of scientific evidence into drug policy
Evan Wood
The myths and reality of hepatitis C in injecting drug users for hepatitis C
Margaret Hellard, Rachel Sacks-Davis, Judy Gold
The need for mainstreaming evidence-based harm reduction
Teguest Guerma, Annette Verster, Andrew Ball, Ying-Ru Lo

3:15pm - 4:30pm POSTER1: Posters - to be assigned to sessions

3:15pm - 4:30pm POSTER2: Posters - to be assigned to sessions

3:15pm - 4:30pm POSTER3: Posters - to be assigned to sessions

3:15pm - 4:30pm CS: Closing
Room 1+1A

[etiquetas: reducción del daño reduccion del dano ]


ver en ihra.net


estás viendo:
Harm Reduction 2010
volver arriba
Reducción del daño Salud


comentarios
Entrar para agregar comentario:
entrar


ricardelico :
Efectuándose esta semana la Conferencia del IHRA en Liverpool. Tweets de @AramBarra al respecto, hasta el momento: @AramBarra en LPL los bares cierran a media noche por ley. eso hace que la gente comience a beber más temprano y que todos consuman más rápido. 8:35 AM Apr 24th via Tweetie @AramBarra 3.30pm y los bares se ven llenos. es una buena perspectiva para la discusión de cierre de antros en el df. @AramBarra Anoche hice de rock star y dimos concierto en medio de liverpool. estuvo de lujo. @AramBarra Evidencia sobre ideología pide Marcus Day en la inauguración de la conferencia sobre reducción de daños. @AramBarra Michel Sidibe pide que se discriminalice a los usuarios de drogas #win @AramBarra A very warm welcoming to @KylaZanardi - tweet, tweet @Youthrise @AramBarra @YouthRISE dio un discurso de apertura sobre jóvenes y uso de drogas que tenía partes de esta canción: http://bit.ly/aIU065 @AramBarra Ya acabé la presentación que haré mañana sobre jóvenes y política de drogas en México. A ver... @AramBarra En unos minutos más me subo a plenaria. chan chan chan. @AramBarra "Young Drug Users: Emerging Drugs and New Trends" Today at 11h30 in Room 1 A! See you there! (via @YouthRISE) / YEAH! @AramBarra La plenaria, de lujo. Entrevista con MTv, bien. Ahora, reunion con activistas de todo el mundo. A ver... @AramBarra Se confirma participacion fuerte en la segunda conferencia regional de politica de drogas (america latina) este verano. preparense! @AramBarra @Lluviarelly @lauramreyna gracias por sus mensajes de apoyo! seguimos- @AramBarra echamos workshop sobre cómo comunicar efectivamente entre varias redes y organizaciones internacionales que fue tan #win que @chunior amaría about 4 hours ago via Tweetie
26/04/2010 | 21:28
en Harm Reduction 2010
   
DrogasMexico.org es un proyecto de Convivencia y Espacio Público AC y el Colectivo por una Política Integral hacia las Drogas AC.
Agradecemos el apoyo de Open Society Foundation, Angelica Foundation y Tides Foundation